Brief: Biorestorative Therapies Announces Clinical Site Initiation For Co's Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease
June 13 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ANNOUNCES CLINICAL SITE
INITIATION FOR
THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE (CLDD)
* BIORESTORATIVE THERAPIES INC- DENVER SPINE AND PAIN
INSTITUTE IS
FIRST CLINICAL SITE TO BE INITIATED
* BIORESTORATIVE THERAPIES INC- ADDITIONAL SELECTED SITES
ARE
EXPECTED TO BE INITIATED IN 2022
Source text for Eikon: ID:nGNX6hrn9R
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM